Transgene: €35.6 Million in Cash and Cash Equivalents as of March 31, 2018 | Business Wire

Transgene: €35.6 Million in Cash and Cash Equivalents as of March 31, 2018 | Business Wire: Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies against cancers